Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights, Forecast to 2025

Table of Contents

1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview

• 1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
• 1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
  • 1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Salicylates
  • 1.2.3 Propionic acid derivatives
  • 1.2.4 Acetic acid derivatives
  • 1.2.5 Enolic acid (Oxicam) derivatives
  • 1.2.6 Anthranilic acid derivatives (Fenamates)
  • 1.2.7 Selective COX-2 inhibitors (Coxibs)
  • 1.2.8 Sulfonanilides
• 1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
  • 1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Human
  • 1.3.3 Animals
  • 1.3.4 Others
• 1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts
  • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2015-2026
  • 1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2015-2026
  • 1.4.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2020 Versus 2026

2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers

• 2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type
• 2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
  • 2.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs (NSAID) Players (Opinion Leaders)

3 Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region

• 3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
  • 3.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
  • 3.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
  • 3.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
  • 3.6.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.6.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.7.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Type

• 4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2015-2020)
• 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2015-2020)
• 4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Market Share by Type (2015-2020)
• 4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Application

• 5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2015-2020)
• 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2015-2020)
• 5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2015-2020)

6 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs (NSAID) Business

• 6.1 Bayer
  • 6.1.1 Corporation Information
  • 6.1.2 Bayer Description, Business Overview and Total Revenue
  • 6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Bayer Products Offered
  • 6.1.5 Bayer Recent Development
• 6.2 Ecotrin
  • 6.2.1 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.2.2 Ecotrin Description, Business Overview and Total Revenue
  • 6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Ecotrin Products Offered
  • 6.2.5 Ecotrin Recent Development
• 6.3 Generic
  • 6.3.1 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.3.2 Generic Description, Business Overview and Total Revenue
  • 6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Generic Products Offered
  • 6.3.5 Generic Recent Development
• 6.4 St. Joseph
  • 6.4.1 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.4.2 St. Joseph Description, Business Overview and Total Revenue
  • 6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 St. Joseph Products Offered
  • 6.4.5 St. Joseph Recent Development
• 6.5 Elanco
  • 6.5.1 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.5.2 Elanco Description, Business Overview and Total Revenue
  • 6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Elanco Products Offered
  • 6.5.5 Elanco Recent Development
• 6.6 Zoetis
  • 6.6.1 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.6.2 Zoetis Description, Business Overview and Total Revenue
  • 6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Zoetis Products Offered
  • 6.6.5 Zoetis Recent Development
• 6.7 Boehringer Ingelheim
  • 6.6.1 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
  • 6.6.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Boehringer Ingelheim Products Offered
  • 6.7.5 Boehringer Ingelheim Recent Development
• 6.8 Merial
  • 6.8.1 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.8.2 Merial Description, Business Overview and Total Revenue
  • 6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Merial Products Offered
  • 6.8.5 Merial Recent Development
• 6.9 Merck Animal Health
  • 6.9.1 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served
  • 6.9.2 Merck Animal Health Description, Business Overview and Total Revenue
  • 6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Merck Animal Health Products Offered
  • 6.9.5 Merck Animal Health Recent Development

7 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis

• 7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
• 7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
• 8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2021-2026)
• 10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2021-2026)
• 10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2021-2026)
• 10.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)
• 10.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)
• 10.7 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List